Literature DB >> 8842354

Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men.

I Rajman1, M J Kendall, R Cramb, R L Holder, M Salih, M D Gammage.   

Abstract

There is an increasing interest in low density lipoprotein (LDL) subfractions since some of them are associated with a higher risk for coronary artery disease (CAD). Small LDL particles are particularly atherogenic and more of those are produced in hypertriglyceridaemia. However, high triglyceride concentrations are not the only explanation for the predominance of small LDL particles and other influences, including genetic factors, are also responsible for LDL particle size. We investigated LDL subfraction profiles in two groups: 46 men with and 21 men without CAD proven angiographically. For the separation of LDL subfractions, we used continuous disc polyacrylamide gel electrophoresis (PAGE) that is rapid and easier to perform than the other methods usually used which, although more precise in terms of measuring particle diameter, are much more demanding of time and equipment. The described method is suitable for routine use in assessing large numbers of patients. All studied men had triglyceride concentrations below 2.3 mmol/l. LDL scores were calculated on the basis of all LDL subfractions present in a particular profile; the higher the score, the greater the proportion of small LDL particles. LDL cholesterol (P < 0.05) and LDL score (P < 0.001) were the only significant discriminators between two groups. LDL score was significantly correlated with CAD, even after adjusting for triglyceride and HDL cholesterol concentrations and it was the best discriminant factor for the presence of CAD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842354     DOI: 10.1016/0021-9150(96)05881-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Women with gestational diabetes should be targeted to reduce cardiovascular risk.

Authors:  V Toescu; S L Nuttall; M J Kendall; U Martin; F Dunne
Journal:  BMJ       Date:  2002-10-26

Review 3.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 4.  ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

Authors:  A F Winder; W Richmond; D T Vallance
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

5.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

6.  Evaluation of lipid profiles and the use of omega-3 essential Fatty Acid in professional football players.

Authors:  Anthony Yates; John Norwig; Joseph C Maroon; Jeffrey Bost; James P Bradley; Mark Duca; Daniel A Wecht; Ryan Grove; Ariko Iso; Ingrid Cobb; Nathan Ross; Meghan Borden
Journal:  Sports Health       Date:  2009-01       Impact factor: 3.843

7.  Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus.

Authors:  Robert S Rosenson; Scott P Rigby; Michael R Jones; Hubert S Chou
Journal:  Cardiovasc Drugs Ther       Date:  2014-06       Impact factor: 3.727

8.  Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.

Authors:  Susan Sam; Steven Haffner; Michael H Davidson; Ralph B D'Agostino; Steven Feinstein; George Kondos; Alfonso Perez; Theodore Mazzone
Journal:  Diabetes       Date:  2008-05-09       Impact factor: 9.461

9.  Human LDL structural diversity studied by IR spectroscopy.

Authors:  José A Fernández-Higuero; Ana M Salvador; Cesar Martín; José Carlos G Milicua; José L R Arrondo
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial.

Authors:  Frédéric Dutheil; Guillaume Walther; Robert Chapier; George Mnatzaganian; Bruno Lesourd; Geraldine Naughton; Julien Verney; Anne Fogli; Vincent Sapin; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Gérard Lac
Journal:  Lipids Health Dis       Date:  2014-07-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.